Based on Technavio's market sizing methodology, the hemostats market size is predicted to surge to USD 925.79 million from 2021 to 2026 at a CAGR of 6.15%.

This hemostats market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers hemostats market segmentation by:

• Type - Matrix and gel hemostats, Sheet and pad hemostats, Sponge hemostats, and Powder hemostats
• Geography - North America, Europe, Asia, and Rest of World (ROW)

The hemostats market report also offers information on several market vendors, including Aegis Lifesciences Pvt Ltd., Axio Biosolutions Pvt Ltd, B. Braun SE, Baxter International Inc., Becton Dickinson and Co., Cryolife Inc., CuraMedical BV, Ergomed Plc, Gelita AG, Grayline Medical Inc., Integra Lifesciences Holdings Corp., Johnson and Johnson, MBP Medical Biomaterial Products GmbH, Pfizer Inc., STERIS Plc, Ted Pella Inc., Towne Brothers Pvt. Ltd., World Precision Instruments, Ydm Corp., and Teleflex Inc. among others.

What will the Hemostats Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Hemostats Market Size for the Forecast Period and Other Important Statistics

Hemostats Market: Key Drivers, Trends, and Challenges

The growing volume of surgical procedures performed is notably driving the hemostats market growth, although factors such as the dearth of medical personnel skilled in the effective use of hemostat products may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the hemostats industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Hemostats Market Driver

• One of the key factors driving growth in the hemostats market is the growing volume of surgical procedures performed.
• Adhesion formation is a prominent post-surgical complication that causes health-related issues and often necessitates the repeat of surgical procedures for affected individuals. Because of the serious consequences of post-surgery adhesion formation in patients, the use of adhesion barrier products like hemostats is growing in the market. 
• The number of surgical procedures performed over the years around the world has increased.
• Globally, 310 million major procedures are performed each year, with 40-50 million surgical procedures performed in the US and 20 million surgeries in Europe.
• Obesity and other lifestyle problems, the aging of the population worldwide, the rising prevalence of orthopedic conditions, and the incidence of spinal and sports-related injuries are all contributing factors. As a result, there is a high demand for hemostats as many surgeons prefer to use them in surgical procedures.

Key Hemostats Market Trend

• The rise in the number of hospitals and surgical centers is a hemostats market trend that is expected to have a positive impact in the coming years.
• The number of hospitals and surgical centers in both developed and developing countries is growing. Due to the growing patient population, surgical devices, such as hemostats, are in great demand in the new surgical centers and hospitals being constructed in these countries.
• Developing countries like India and China have seen tremendous advancements in their healthcare infrastructure over the previous decade.
• As of January 2022, in India, nineteen institutes (branches) of the All India Institutes of Medical Sciences (AIIMS) are operating, and five more are expected to open by 2025.
• The global hemostats market is likely to benefit from the significant increase in the number of hospitals and surgical centers, as they are the primary end consumers of hemostats. Thus, the rise in the number of hospitals and surgical centers will drive the growth of the global hemostats market.

Key Hemostats Market Challenge

• The dearth of medical personnel skilled in the effective use of hemostat products will be a major challenge for the hemostats market during the forecast period.
• Hemostats must be handled by trained medical personnel since poor artery closure during surgical procedures might result in continued bleeding or ischemia. Some devices even require several steps to be completed before they can be used.
• One of the major factors restricting the adoption of hemostats is the scarcity of experienced surgeons in both developed countries and emerging economies.
• The technological landscape and application areas of hemostat products are changing rapidly due to technical advancements in the healthcare industry. This makes it necessary for physicians and other healthcare practitioners to learn how to use sophisticated products such as hemostats, bone graft alternatives, surgical sealants, and adhesives properly. Such factors may hinder the growth of the global hemostats market during the forecast period.

This hemostats market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global hemostats market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the hemostats market during the forecast period.

Who are the Major Hemostats Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

• Aegis Lifesciences Pvt Ltd.
• Axio Biosolutions Pvt Ltd
• B. Braun SE
• Baxter International Inc.
• Becton Dickinson and Co.
• Cryolife Inc.
• CuraMedical BV
• Ergomed Plc
• Gelita AG
• Grayline Medical Inc.
• Integra Lifesciences Holdings Corp.
• Johnson and Johnson
• MBP Medical Biomaterial Products GmbH
• Pfizer Inc.
• STERIS Plc
• Ted Pella Inc.
• Towne Brothers Pvt. Ltd.
• World Precision Instruments
• Ydm Corp.
• Teleflex Inc.

This statistical study of the hemostats market encompasses successful business strategies deployed by the key vendors. The hemostats market is fragmented and the vendors are deploying growth strategies such as focusing on inorganic growth strategies such as M&A to maximize sales volume to compete in the market.

Product Insights and News

• aegis-lifesciences.com - The company offers hemostats products such as SURGISPON haemostatic powder PS kit.
• aegis-lifesciences.com - Under the unified segment, company offers hemostats products such as SURGISPON haemostatic powder PS kit.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The hemostats market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Hemostats Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the hemostats market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Hemostats Market?

For more insights on the market share of various regions Request for a FREE sample now!

39% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for hemostats in North America. Market growth in this region will be slower than the growth of the market in the European and Asian regions.

The presence of modern healthcare systems, as well as their well-established nature will facilitate the hemostats market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The COVID-19 pandemic in 2020 certainly had a negative impact on the global hemostats market in North America, as it resulted in the temporary closure of various industries, including manufacturing facilities. However, in 2021, the demand for hemostats rebounded as hospitals and other healthcare facilities resumed surgical treatments following the large-scale COVID-19 vaccination drives conducted in the region. These factors will drive the growth of the regional hemostats market during the forecast period.

What are the Revenue-generating Type Segments in the Hemostats Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The hemostats market share growth by the matrix and gel hemostats segment will be significant during the forecast period. The advantages of these hemostats, such as ease of application, biocompatibility, and cost-effectiveness, account for their considerable share in the market. Flowable hemostatic agents have the ability to cover irregularly shaped wound surfaces, fill deep lesions, and easily remove surplus material using irrigation, making them more favorable than non-flowable hemostatic agents. Flowable hemostatic agents outperform traditional approaches in a variety of surgical procedures. A flowable hemostatic matrix, such as FloSeal, can halt bleeding fast and reliably in a variety of situations. Such factors will contribute to the growth of the segment during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the hemostats market size and actionable market insights on post COVID-19 impact on each segment.

Request for a FREE sample

What are the Key Data Covered in this Hemostats Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive hemostats market growth during the next five years
• Precise estimation of the hemostats market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the hemostats industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of hemostats market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch